The cytochrome P450 isoenzyme and some new opportunities for the prediction of negative drug interaction in vivo

Autor: Sychev DA, Ashraf GM, Svistunov AA, Maksimov ML, Tarasov VV, Chubarev VN, Otdelenov VA, Denisenko NP, Barreto GE, Aliev G

Publikováno v: Drug Design, Development and Therapy, Vol Volume 12, Pp 1147-1156 (2018)

Dmitrij A Sychev,1 Ghulam Md Ashraf,2 Andrey A Svistunov,3 Maksim L Maksimov,4 Vadim V Tarasov,3 Vladimir N Chubarev,3 Vitalij A Otdelenov,1 Natal’ja P Denisenko,1 George E Barreto,5,6 Gjumrakch Aliev7–9 1Russian Medical Academy of Postgraduate E

Externí odkaz: https://doaj.org/article/084a5e689b81484c82b063dd7653eb8c

[Pulmonary paecilomycosis: Diagnosis and treatment].

Autor: Strelyaeva AV; I.M. Sechenov First Moscow State Medical University, Ministry of Health of Russia, Moscow, Russia., Svistunov AA; I.M. Sechenov First Moscow State Medical University, Ministry of Health of Russia, Moscow, Russia., Dzhomaa RA; I.M. Sechenov First Moscow State Medical University, Ministry of Health of Russia, Moscow, Russia., Sapozhnikov SA; I.M. Sechenov First Moscow State Medical University, Ministry of Health of Russia, Moscow, Russia., Chebyshev NV; I.M. Sechenov First Moscow State Medical University, Ministry of Health of Russia, Moscow, Russia., Ashurov AA; Samarkand State Medical Institute, Samarkand, Republic of Uzbekistan., Maksimov ML; I.M. Sechenov First Moscow State Medical University, Ministry of Health of Russia, Moscow, Russia., Lazareva NB; I.M. Sechenov First Moscow State Medical University, Ministry of Health of Russia, Moscow, Russia., Gabchenko AK; Samarkand State Medical Institute, Samarkand, Republic of Uzbekistan., Sadykov VM; Samarkand State Medical Institute, Samarkand, Republic of Uzbekistan.

Publikováno v: Terapevticheskii arkhiv [Ter Arkh] 2015; Vol. 87 (3), pp. 53-58.

[Clinical cfficacy of calcium channel blockers slow the third generation of lercanidipine in the treatment of patients with arterial hypertension].

Autor: Maksimov ML, Malykhina AI

Publikováno v: Kardiologiia [Kardiologiia] 2013; Vol. 53 (6), pp. 85-90.

[Correction of aldosterone level as marker of RAAS dysfunction in patients with arterial hypertension degree II-III and chronic kidney diseases].

Autor: Dralova OV, Maksimov ML, Derbentseva EA, Ermolaeva AS, Starodubtsev AK

Publikováno v: Eksperimental'naia i klinicheskaia farmakologiia [Eksp Klin Farmakol] 2011; Vol. 74 (4), pp. 14-7.

[Application of AT1-angiotensin II receptor blocker valsartan in clinical practice].

Autor: Maksimov ML, Mochkin IA, Starodubtsev AK

Publikováno v: Kardiologiia [Kardiologiia] 2011; Vol. 51 (8), pp. 77-84.